AstraZeneca Pharmaceuticals LP v. Cobalt Pharmaceuticals Inc.
1:07-cv-00811
Overview
Parties
Movant
AstraZeneca Pharmaceuticals LP NPE (Individual / Inventor)
Represented By
3 Attorneys ListedDefendant
Plaintiff
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° RadarMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
MUSC Foundation for Research Development v. AstraZeneca Pharmaceuticals LP
MUSC Foundation for Research Development v. AstraZeneca Pharmaceuticals LP
AstraZeneca UK Limited v. Watson Pharmaceuticals Inc.
AstraZeneca Pharmaceuticals LP v. Par Pharmaceutical Inc.
Patents Involved
There are 2 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
USRE37314
Pyrimidine derivatives
|
Filed: 1998-08-27
Issued: 2001-08-07
|
Expired (Term Ended)
Expires: 2016-01-08
|
|
|
US6316460
Pharmaceutical compositions
|
Filed: 2000-08-04
Issued: 2001-11-13
|
Expired (Term Ended)
Expires: 2020-08-04
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.
Standard Statutory Term β No obviousness-type double patenting truncation noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
104
Dispositive
71
Granted
3
Denied
1
Pending / Review
79
Motions by Category
Key Dispositive Motions & Rulings